EUVIMEDEUVIMED entdecken
BeobachtungsstudieStudienprotokollOpen Access · CC BY-NC-ND 4.0

Evaluating the Impact of a Standardized Protocol for Managing Refractory Vasoplegia After Cardiopulmonary Bypass

Andrew Teletnick, Kangho Suh, Michael Boisen, James A Brown, Bernardine Cabral, Holt Murray, Caroline Paley, Danine Sullinger, Ibrahim Sultan, Floyd Thoma, Joseph Williams, Kathirvel Subramaniam und 1 weitere

Journal of Cardiothoracic and Vascular Anesthesia · 2026

DOI: 10.1053/j.jvca.2026.02.003 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2026. Verfasst von Andrew Teletnick und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, UPMC Presbyterian Hospital, Pittsburgh, PA. Electronic address: teletnicka@upmc.edu. Hauptthemen laut MEDLINE: Cardiopulmonary Bypass, Clinical Protocols, Postoperative Complications, Vasoplegia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to evaluate the hemodynamic impact and cost-effectiveness of a standardized protocol for refractory vasoplegia occurring after cardiopulmonary bypass (CPB). DESIGN: Observational, pre-post study. SETTING: A single-center, academic teaching hospital. PARTICIPANTS: Cardiothoracic surgery patients requiring CPB who received at least a single rescue agent (angiotensin II, hydroxocobalamin [a form of vitamin B12], or methylene blue [MB]) perioperatively for refractory vasoplegia. INTERVENTIONS: Refractory vasoplegia was defined as at least 0.25 μg/kg/min norepinephrine equivalents (NEeq), and a stepwise treatment protocol was developed, escalating from MB to angiotensin II and hydroxocobalamin. Patients undergoing CPB after protocol implementation were compared with patients undergoing CPB before protocol implementation, who received rescue agents at the discretion of the managing provider. MEASUREMENTS AND MAIN RESULTS: The study included 215 patients, with 119 and 96 patients in the pre- and post-protocol groups, respectively. There was no difference in mean NEeq requirement preceding rescue agent administration (0.32 μg/kg/min v 0.31 μg/kg/min). Post-protocol patients experienced a steeper rate of decline in percentage change in NEeq in the initial 3 hours (-2.01% NEeq per 15-minute interval, p < 0.01) and an average cost reduction in vasoactive agents of 30% (p < 0.01) and 26% (p < 0.01) at 24 and 48 hours, respectively. No differences in short-term clinical outcomes were observed between groups. CONCLUSIONS: Implementation of a stepwise protocol using MB, angiotensin II, and hydroxocobalamin for refractory vasoplegia resulted in significant cost savings, hastened NEeq reduction, and similar short-term clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiopulmonary BypassClinical ProtocolsPostoperative ComplicationsVasoplegiaAgedFemaleHumansMaleMiddle AgedAngiotensin IIHydroxocobalaminMethylene BlueCost-Effectiveness Analysis

Stichwörter der Autor:innen

angiotensin IIcardiopulmonary bypasshydroxocobalaminmethylene bluerefractory vasoplegia

Substanzen

Angiotensin IIHydroxocobalaminMethylene Blue

Autor:innen und Institutionen

  • Department of Pharmacy, UPMC Presbyterian Hospital, Pittsburgh, PA. Electronic address: teletnicka@upmc.edu.
  • School of Pharmacy, University of Pittsburgh, Pittsburgh, PA. Electronic address: KAS551@pitt.edu.
  • Department of Anesthesiology, University of Pittsburgh, Pittsburgh, PA. Electronic address: boisenml@upmc.edu.
  • Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA. Electronic address: brownja7@upmc.edu.
  • Department of Anesthesiology, University of Pittsburgh, Pittsburgh, PA. Electronic address: cabralb@upmc.edu.
  • Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA. Electronic address: murrhn@upmc.edu.

Zitieren

APA

Teletnick, A., Suh, K., Boisen, M., Brown, J. A., Cabral, B., Murray, H., Paley, C., Sullinger, D., Sultan, I., Thoma, F., Williams, J., Subramaniam, K., & Rivosecchi, R. M. (2026). Evaluating the Impact of a Standardized Protocol for Managing Refractory Vasoplegia After Cardiopulmonary Bypass. Journal of Cardiothoracic and Vascular Anesthesia. https://doi.org/10.1053/j.jvca.2026.02.003

Vancouver

Teletnick A, Suh K, Boisen M, Brown JA, Cabral B, Murray H, et al. Evaluating the Impact of a Standardized Protocol for Managing Refractory Vasoplegia After Cardiopulmonary Bypass. Journal of Cardiothoracic and Vascular Anesthesia. 2026. doi:10.1053/j.jvca.2026.02.003

BibTeX
@article{Teletnick2026,
  author = {Teletnick, Andrew and Suh, Kangho and Boisen, Michael and Brown, James A and Cabral, Bernardine and Murray, Holt and Paley, Caroline and Sullinger, Danine and Sultan, Ibrahim and Thoma, Floyd and Williams, Joseph and Subramaniam, Kathirvel and Rivosecchi, Ryan M},
  title = {Evaluating the Impact of a Standardized Protocol for Managing Refractory Vasoplegia After Cardiopulmonary Bypass},
  journal = {Journal of Cardiothoracic and Vascular Anesthesia},
  year = {2026},
  doi = {10.1053/j.jvca.2026.02.003}
}
Kostenlos starten →